Le Lézard
Classified in: Health, Business
Subject: SCZ

Sonata Senior Living Plans $52 Million Community in Lake Mary


ORLANDO, Fla., Sept. 12, 2019 /PRNewswire/ -- Sonata Senior Living has announced plans to develop Sonata Lake Mary, a $52 million resort-style community in Lake Mary, Florida. Located on a seven-acre site within the Lake Wellness and Technology Park mixed-use development near Primera Blvd. and Reinhart Rd., the property will feature 88 independent living, 92 assisted living and 13 memory care apartments. 

Sonata Lake Mary is expected to break ground in early 2020, making it the 12th community for Orlando-based Sonata Senior Living, a privately held senior housing developer and operator.

Sonata Lake Mary will offer a convenient rental contract and continuum of care for aging in place. The four-story building will incorporate the latest design and technology innovations with spacious apartments and upscale amenities along with the exceptional service and care that is a Sonata Senior Living trademark.

"Hospitality is at the center of all Sonata Senior Living Communities," said Shelley Esden, COO of Sonata Senior Living. "Sonata Lake Mary will build on this philosophy and align with the modern-day expectations of seniors who desire more choices."

The community will feature multiple dining venues; a full-service and juice bar; fitness center and spa; bocce ball court; putting green; theater; pool; and dog park, among other amenities. Innovations such as a simulated golf center will cater to the active senior lifestyle.

The location of Sonata Lake Mary within the 153-acre, estimated $750 million Lake Wellness and Technology Park will ideally place the community in close proximity to a hospital, urgent care facility and medical pavilion.

According to Richard Toomey of LMLD, LLC, and master developer of the Lake Wellness and Technology Park, Orlando Health plans to start construction of the $470 million, 240-bed hospital in 2020 as well as planning for another 84,000-square-feet of medical office space within walking distance to Sonata Lake Mary.

President Jim Heistand of LMLD's parent company, Parkway Property Investments, LLC, stated, "Richard has assembled a fantastic group of businesses for the Lake Wellness and Technology Park and senior housing is an essential component of our plan to create a sustainable live, work and medical wellness town center."

"We are building a community within a community and our presence in the park squarely places the emphasis on wellness in senior living, which is something we are passionate about," said Esden. "The location in the Lake Wellness and Technology Park will provide our residents convenient access to world-class medical facilities in addition to our own signature care."

The 250,000-square-foot senior living community will create approximately 200 jobs during construction and 85 permanent jobs in Lake Mary upon opening in 2021.

About Sonata Senior Living
Sonata Senior Living is a licensed owner, developer and operator of independent living, assisted living and memory care communities located exclusively in Florida. Recognized by Argentum as a Best of the Best Award recipient, Sonata Senior Living is committed to enriching the lives of older adults through constant innovation, programming and services that recognize individuality and personal choice. Partners include the Florida Senior Living Association, the Alzheimer's Association, Teepa Snow's Positive Approachtm to Care and Argentum. For more information visit www.sonataseniorliving.com or call Shelley Esden at 407-286-6490. 

Contact: Shelley Esden
Phone: (407) 286-6490
Email: 222850@email4pr.com

SOURCE Sonata Senior Living


These press releases may also interest you

at 13:05
Cortexyme, Inc. today announced the presentation of new data supporting the on-target activity of COR388, its lead investigational medicine, and linking the "gingipain hypothesis" for Alzheimer's disease (AD) to the significance of the APOE gene as...

at 12:05
Stoke Therapeutics, Inc. , a biotechnology company pioneering a new way to treat the underlying cause of severe genetic diseases by precisely upregulating protein expression, today announced preclinical data from studies of STK-001 that showed...

at 12:05
Mallinckrodt plc , a global biopharmaceutical company, today announced findings on the use of a novel predictive model designed to more quickly identify infants with infantile spasms (IS), a rare seizure disorder that typically occurs between three...

at 11:05
Aptose Biosciences Inc. released highlights from a corporate event and clinical update today held at the 61st American Society of Hematology (ASH) Annual Meeting and Exposition in Orlando, FL. The event was hosted by the Aptose management team and...

at 10:25
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today initial results from the Phase 1b/2 CARTITUDE-1 study (NCT03548207) evaluating the efficacy and safety of JNJ-68284528 (JNJ-4528), an investigational B cell maturation antigen...

at 10:20
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced combination data from two studies and a long-term integrated analysis evaluating the use of Imbruvica® (ibrutinib) for the treatment of previously untreated patients with CLL....



News published on 12 september 2019 at 16:30 and distributed by: